Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y F He

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Fa Yi Xue Za Zhi|December 13, 2017
[Genetic Polymorphisms of 30 InDel Loci in Ewenki Ethnic Group from Inner Mongolia]X Y Jin, Y Y Wei, Y F He, et al.
Clinical Radiology|October 1, 2025
A CT radiomics-based machine learning model for predicting high-grade pathological components in stage IA lung adenocarcinoma: a two-center studyZ-S Pu, Y-F He, S-L Qiu, et al.
Cancer|May 7, 2015
Psychometric properties of an Australian supportive care needs assessment tool for Indigenous patients with cancerGail Garvey, Vanessa L Beesley, Monika Janda, et al.
Circulation|July 14, 2016
Long-Term Outcomes From Acute Rheumatic Fever and Rheumatic Heart Disease: A Data-Linkage and Survival Analysis ApproachVincent Y F He, John R Condon, Anna P Ralph, et al.
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases|March 29, 2023
[Analysis of time for diagnosis of nontuberculous mycobacterial lung disease and its associated factors in a tuberculosis-designated hospital in Shanghai]X B Zheng, Y F He, L Wang, et al.
Journal of Clinical Pharmacy and Therapeutics|May 3, 2008
Analysis of the DPYD gene implicated in 5-fluorouracil catabolism in Chinese cancer patientsY-F He, W Wei, X Zhang, et al.
Zhonghua Nei Ke Za Zhi|January 4, 2022
[Re-evaluation of the diagnostic value and optimal cutoff point of captopril challenge test in diagnosis of primary aldosteronism]Y Luo, W W He, Q F Cheng, et al.
European Journal of Cancer Care|March 8, 2016
Preoperative NLR and PLR in the middle or lower ESCC patients with radical operationY-F He, H-Q Luo, W Wang, et al.
Zhonghua Nei Ke Za Zhi|January 8, 2026
[Intra-individual variability of plasma aldosterone and renin and implications for screening for primary aldosteronism]Z J Su, Y X Zhang, J L Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2013
Isocitrate dehydrogenase 1 is a novel plasma biomarker for the diagnosis of non-small cell lung cancerNan Sun, Zhaoli Chen, Fengwei Tan, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Fa Yi Xue Za Zhi|December 13, 2017
[Genetic Polymorphisms of 30 InDel Loci in Ewenki Ethnic Group from Inner Mongolia]X Y Jin, Y Y Wei, Y F He, et al.
Clinical Radiology|October 1, 2025
A CT radiomics-based machine learning model for predicting high-grade pathological components in stage IA lung adenocarcinoma: a two-center studyZ-S Pu, Y-F He, S-L Qiu, et al.
Cancer|May 7, 2015
Psychometric properties of an Australian supportive care needs assessment tool for Indigenous patients with cancerGail Garvey, Vanessa L Beesley, Monika Janda, et al.
Circulation|July 14, 2016
Long-Term Outcomes From Acute Rheumatic Fever and Rheumatic Heart Disease: A Data-Linkage and Survival Analysis ApproachVincent Y F He, John R Condon, Anna P Ralph, et al.
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases|March 29, 2023
[Analysis of time for diagnosis of nontuberculous mycobacterial lung disease and its associated factors in a tuberculosis-designated hospital in Shanghai]X B Zheng, Y F He, L Wang, et al.
Journal of Clinical Pharmacy and Therapeutics|May 3, 2008
Analysis of the DPYD gene implicated in 5-fluorouracil catabolism in Chinese cancer patientsY-F He, W Wei, X Zhang, et al.
Zhonghua Nei Ke Za Zhi|January 4, 2022
[Re-evaluation of the diagnostic value and optimal cutoff point of captopril challenge test in diagnosis of primary aldosteronism]Y Luo, W W He, Q F Cheng, et al.
European Journal of Cancer Care|March 8, 2016
Preoperative NLR and PLR in the middle or lower ESCC patients with radical operationY-F He, H-Q Luo, W Wang, et al.
Zhonghua Nei Ke Za Zhi|January 8, 2026
[Intra-individual variability of plasma aldosterone and renin and implications for screening for primary aldosteronism]Z J Su, Y X Zhang, J L Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2013
Isocitrate dehydrogenase 1 is a novel plasma biomarker for the diagnosis of non-small cell lung cancerNan Sun, Zhaoli Chen, Fengwei Tan, et al.
Pageof 7